Helping make medicine personal—microarray solutions for pre-emptive pharmacogenomics

Pharmacogenomics, the understanding of how genes impact an individual’s response to medications, play an important role in certain prescribing situations by identifying medication responders and non-responders to avoid specific adverse events and optimize drug dose. 


Thermo Fisher Scientific’s microarray technology helps garner new, greater insights to help make medicine personal. Our efficient workflows provide consistent, reliable results you can replicate. We provide input on what’s needed to customize your array, with hands-on support from start to finish so you can remain focused on shaping the future of healthcare.


Customer and solutions overview

Implementing preemptive PGx program in a pediatric hospital

Dr. Steven Melnick and Dr. David B. Mancuso from Nicklaus Children's Hospital discuss implementing a preemptive pharmacogenomics program in a hospital.

Current state of pharmacogenomics and its future

Ray Lorenz of Quest Diagnostics discusses how pharmacogenomics aids providers in optimizing drug selection and dosing.

Genotyping techniques used by researchers

This webinar series explores how researchers utilize genotyping techniques like microarray analysis, NGS, and PCR to address various applications.

Understanding a shifting tech landscape

In this webinar, three essential whole-genome technologies are introduced  their integration into research technology strategies is explored.

Pharmacogenomics in precision medicine: Pathways to ease adoption

Dr. Solomon Adams walks viewers through the pharmacogenomics (PGx) program at Ariel Precision Medicine and plans for empowering patients to use PGx data with multiple providers.

Which technology platform is right for you?

Explore the advances and trade-offs of three different technologies in the context of genomic discovery.

Custom arrays




Microarray Research Services Laboratory